Integer Holdings Co. (NYSE:ITGR) Given Average Rating of “Moderate Buy” by Analysts

Shares of Integer Holdings Co. (NYSE:ITGR) have been given an average recommendation of “Moderate Buy” by the eight brokerages that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $139.75.

A number of research firms have weighed in on ITGR. KeyCorp boosted their target price on shares of Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research note on Tuesday, October 15th. Benchmark boosted their price objective on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, October 21st. Citigroup upped their target price on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. Truist Financial lowered their price objective on shares of Integer from $150.00 to $147.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Finally, Piper Sandler restated an “overweight” rating and issued a $140.00 target price (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th.

Integer Stock Performance

Shares of Integer stock opened at $140.50 on Monday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The business has a 50 day moving average price of $131.38 and a 200-day moving average price of $124.50. Integer has a 52 week low of $84.75 and a 52 week high of $142.00. The company has a market cap of $4.71 billion, a PE ratio of 43.36, a price-to-earnings-growth ratio of 2.01 and a beta of 1.09.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.27 EPS. Equities analysts anticipate that Integer will post 5.33 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Driehaus Capital Management LLC boosted its position in shares of Integer by 62.5% during the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after purchasing an additional 135,750 shares in the last quarter. Eagle Asset Management Inc. purchased a new position in shares of Integer in the third quarter worth $14,403,000. F M Investments LLC purchased a new position in Integer in the 2nd quarter worth about $11,143,000. Point72 Europe London LLP bought a new position in Integer during the second quarter valued at approximately $6,241,000. Finally, Bamco Inc. NY grew its holdings in shares of Integer by 17.4% in the third quarter. Bamco Inc. NY now owns 254,377 shares of the medical equipment provider’s stock worth $33,069,000 after acquiring an additional 37,700 shares during the period. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.